Clinical Professor
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Leeds, United Kingdom
Gordon Cook is a graduate of the University of Glasgow School of Medicine & received my higher professional training in haematology in the West of Scotland. After completion of my PhD, I was appointed as a Consultant Haematologist in the West of Scotland before moving to take up the post of Director of Stem Cell Transplantation at Leeds Teaching Hospitals in 2002. In 2013 I was appointed as Professor of Haematology, University of Leeds where I lead the myeloma clinical and translational research programme with a primary interest in tumour immunology and immunotherapy.
I was the founder & first Chair of the UK Myeloma Research Alliance. I am the past-chair of the UK Myeloma Society and established the College of Myeloma (UK) which elected its first fellows in 2019. I have represented the interests of both myeloma clinicians and patients in National Institute of Clinical care & Excellence reviews and technology appraisals. I am the NHS England Advanced Cellular Therapies Lead for myeloma. I was appointed as the chair of the NCRI Haemato-oncologist Clinical Studies Group in 2022.
I have developed and delivered an extensive national clinical research portfolio. Currently, I am Chief Investigator for NCRI Myeloma X (completed), UKMRA Myeloma XII (in follow-up), UKMRA Myeloma XIV (in follow-up), UKMRA Myeloma XVIII iFIT (at funding) MUKeight (completed) and MUKeleven (completed). My collaboration with industry includes my position as the UK Chief investigator for 6 industry international phase III and IIIb studies.
I hold the posts of Co-Director of the Leeds Cancer Research Centre and Clinical Director of National Institute of Health Research (Leeds) Medtech & In Vitro Diagnostics Cooperative and Clinical Director (Haematology), Clinical Trials Research Unit, University of Leeds. I have been elected to National Institute for Health and Care Research Senior Investigator in 2024.
Disclosure information not submitted.
Meet the Expert: Frailty-adapted therapy
Thursday, September 26, 2024
7:00 AM – 8:00 AM East Coast USA Time